๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Corticosteroid

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 18 trials in our USA, China, UK and India registers that name Corticosteroid as an intervention. Synced 24 Sep 2026
18Trials tracked
7Recruiting now
15Lead sponsors
4Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards

Corticosteroid is named as a drug or biological intervention in 18 clinical trials in our USA, China, UK and India trial registers, 7 of which are recruiting. Lead sponsors include InGeneron, Inc. (3), Eli Lilly and Company (2) and Merit Medical Systems, Inc. (1). Registered phases: Not applicable, Phase 3, Phase 4, Phase 2, Phase 1/2 and Phase 2/3. Conditions studied include Atopic Dermatitis; Knee Osteoarthritis; Osteo Arthritis Knee.

01

Clinical trials of Corticosteroid

18 trials
NCT IDStudyPhaseStatusLead sponsorRegister
NCT07077486 Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease (ClinicalTrials.gov ↗)
Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
Phase 4 Recruiting Tongji Hospital China
NCT07546097 Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis๏ผˆUPFRONT๏ผ‰ (ClinicalTrials.gov ↗)
Acute Severe Ulcerative Colitis
Phase 4 Recruiting Yongquan Shi China
NCT07611214 PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis (ClinicalTrials.gov ↗)
Lupus Nephritis
Phase 4 Recruiting Aurinia Pharmaceuticals Inc. USA
NCT04381936 Randomised Evaluation of COVID-19 Therapy (ClinicalTrials.gov ↗)
Pneumonia
Phase 3 Recruiting University of Oxford India
NCT06213649 Parasitic Ulcer Treatment Trial (ClinicalTrials.gov ↗)
Acanthamoeba Keratitis
Phase 3 Recruiting Jeremy Keenan, MD, MPH India
NCT06780085 A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Carcinoma, Non-Small-Cell Lung
Phase 2 Recruiting Merck Sharp & Dohme LLC USA
NCT03513731 Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint (ClinicalTrials.gov ↗)
Osteoarthritis of Facet Joint of Lumbar Spine
Not applicable Recruiting InGeneron, Inc. USA
NCT06762145 EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) (ClinicalTrials.gov ↗)
Transcatheter Aortic Valve Replacemen, Left Bundle Branch Block
Phase 4 Not yet open Xiao-dong Zhuang China
NCT07542288 Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases: (ClinicalTrials.gov ↗)
Brain Metastases From Solid Tumors
Phase 2/3 Not yet open The Second Affiliated Hospital of Hainan Medical University China
NCT07737249 Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease (ClinicalTrials.gov ↗)
Interstitial Lung Diseases
Phase 2 Not yet open Peking Union Medical College Hospital China
NCT05559359 A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ClinicalTrials.gov ↗)
Atopic Dermatitis, Eczema
Phase 3 Active, closed Eli Lilly and Company USA
NCT06280716 A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis (ClinicalTrials.gov ↗)
Atopic Dermatitis
Phase 3 Active, closed Eli Lilly and Company China
NCT07098897 To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy (ClinicalTrials.gov ↗)
IgA Nephropathy (IgAN)
Phase 3 Active, closed The Affiliated Hospital of Xuzhou Medical University China
NCT05067140 A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer (ClinicalTrials.gov ↗)
Prostate Cancer Metastatic
Phase 1/2 Active, closed Novartis Pharmaceuticals USA
NCT03503305 Healing Osteoarthritic Joints in the Wrist With Adult ADRCs (ClinicalTrials.gov ↗)
Osteoarthritis of the Wrist
Not applicable Active, closed InGeneron, Inc. USA
NCT03752827 Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
Rotator Cuff Tear, Rotator Cuff Tendinitis
Not applicable Active, closed InGeneron, Inc. USA
NCT05818150 GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION) (ClinicalTrials.gov ↗)
Knee Osteoarthritis
Not applicable Active, closed Merit Medical Systems, Inc. UK, USA
NCT06550024 SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization (ClinicalTrials.gov ↗)
Osteo Arthritis Knee, Joint Diseases, Musculoskeletal Diseases
Not applicable Active, closed CrannMed UK, USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied

25 conditions
Condition (as registered)Trials
Atopic Dermatitis2
Knee Osteoarthritis1
Osteo Arthritis Knee1
Joint Diseases1
Musculoskeletal Diseases1
Rheumatic Diseases1
Carcinoma, Non-Small-Cell Lung1
Rotator Cuff Tear1
Rotator Cuff Tendinitis1
Prostate Cancer Metastatic1
Eczema1
Lupus Nephritis1
Osteoarthritis of Facet Joint of Lumbar Spine1
Osteoarthritis of the Wrist1
Pneumonia1
Acanthamoeba Keratitis1
Interstitial Lung Diseases1
Acute Severe Ulcerative Colitis1
IgA Nephropathy (IgAN)1
Brain Metastases From Solid Tumors1
Lupus or SLE1
Interstitial Lung Disease1
Systemic Lupus Erythematosus1
Transcatheter Aortic Valve Replacemen1
Left Bundle Branch Block1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
InGeneron, Inc.3
Eli Lilly and Company2
Merit Medical Systems, Inc.1
CrannMed1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Aurinia Pharmaceuticals Inc.1
University of Oxford1
Jeremy Keenan, MD, MPH1
Peking Union Medical College Hospital1
Yongquan Shi1
The Affiliated Hospital of Xuzhou Medical University1
The Second Affiliated Hospital of Hainan Medical University1
Tongji Hospital1
Xiao-dong Zhuang1
04

Trials by country register

A trial with sites in more than one country appears in each of those registers.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Corticosteroid works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Corticosteroid (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.